Additionally, in our study the increased risk of breast cancer linked to ERCC1 rs11615 more prominent in postmenopausal females and patients with positive expression of PR and ER, indicating the risk conveyed by this polymorphism to breast cancer in menopausal females [30]. This evidence concerns the gene PGR and breast carcinoma.